OUR COMPANY

Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market.

Pernix Therapeutics promotes its branded products to Healthcare Providers through its internal sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, L.L.C. and Cypress Pharmaceuticals, Inc.

OUR MEDICINES

Pernix Therapeutics is dedicated to addressing unmet needs within central nervous system (CNS) indications, including pain, neurology, and psychiatry, as well as other specialty therapeutic areas.

Our Purpose
At Pernix we challenge ourselves to think differently, and inspire each other to enhance the lives of patients by providing access to life changing medications.

Our Values
Integrity
We hold ourselves to the highest standard, while doing the right thing.

Passion
Through our actions we inspire each other to improve the lives of patients.

Accountability
Recognize it, own it, act on it.

Commitment
To ethically deliver value to patients, employees, customers and shareholders.

Teamwork
Together we are limitless: working together for the greater good of patients, colleagues and stakeholders.